Clinical Trials Logo

Rhinitis clinical trials

View clinical trials related to Rhinitis.

Filter by:

NCT ID: NCT01052610 Recruiting - Allergic Rhinitis Clinical Trials

Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites

Start date: June 2010
Phase: Phase 4
Study type: Interventional

The purpose of the trial is to asses the efficacy and safety of sublingual annual immunotherapy in children with bronchial asthma and/or allergic rhinitis allergic to house dust mites.

NCT ID: NCT01050465 Completed - Obesity Clinical Trials

MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use

Start date: May 2009
Phase: N/A
Study type: Interventional

The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.

NCT ID: NCT01038427 Completed - Clinical trials for Rhinitis, Allergic, Seasonal

A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Start date: December 2, 2009
Phase: Phase 3
Study type: Interventional

This study compared the efficacy and safety of a generic mometasone nasal spray to the reference listed drug in the treatment of seasonal allergic rhinitis. Additionally both the test and the reference formulations were tested for superiority against a placebo nasal spray.

NCT ID: NCT01033825 Completed - Clinical trials for Perennial Allergic Rhinitis

Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis

Start date: January 2010
Phase: Phase 3
Study type: Interventional

To demonstrate the effects of ciclesonide applied as a nasal aerosol and ciclesonide aqueous (AQ) nasal spray on hypothalamic-pituitary-adrenal axis.

NCT ID: NCT01033396 Completed - Allergic Rhinitis Clinical Trials

The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis

Start date: January 2010
Phase: Phase 2
Study type: Interventional

PF-03654764 should reduce the symptoms of allergic rhinitis. In this study patients will be exposed to pollen and their symptoms observed.

NCT ID: NCT01030146 Completed - Rhinitis Clinical Trials

Management of Allergic Rhinitis Patients With Nasal Steroids and NeilMed® Sinus Rinseā„¢ System With Isotonic Saline

Start date: December 2009
Phase: N/A
Study type: Interventional

You are being asked to volunteer for a research study. You are being asked to participate in this study because you have completed at least one month of drug treatment with a nasal steroid and allergy testing and still have symptoms. This research study is sponsored by NeilMed Pharmaceuticals, Inc. The purpose of this study is to compare quality of life outcomes in patients who continue medical treatment plus the use of the NeilMed Sinus Rinse low-pressure pump with saline. Your participation in this study may help to improve the management of patients with allergic rhinitis. Allergic rhinitis is a common health problem, affecting between 10% and 40% of the world's population. Presently, antihistamines and nasal steroids are the standard treatment for allergic rhinitis. To further clarify these findings, we propose a study comparing the differences in quality of life improvements, by using a series of questionnaires, between subjects electing continued medical management and those electing medical treatment plus nasal wash. The investigators in charge of the study are Dr. Rodney J. Schlosser and Dr. Shaun A. Nguyen. Approximately 40 patients will be enrolled in this study at the Medical University of South Carolina (MUSC Hospital). You will have the choice of choosing either to receive only medical treatment or to receive medical treatment with nasal wash.

NCT ID: NCT01024608 Completed - Clinical trials for Seasonal Allergic Rhinitis

Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

Start date: December 31, 2009
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the efficacy and safety of an investigational nasal aerosol compared with placebo nasal aerosol in the treatment of seasonal allergic rhinitis.

NCT ID: NCT01022047 Completed - Allergic Rhinitis Clinical Trials

Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis

NOEX
Start date: February 2010
Phase: Phase 3
Study type: Interventional

To assess the efficacy of the study product Noex in the treatment of allergic rhinitis by means of the Nasal Index Score (NIS) after 4 weeks of treatment with the drug.

NCT ID: NCT01018862 Completed - Clinical trials for Perennial Allergic Rhinitis

A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis

Start date: November 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the effectiveness of an Investigational use of an allergy medication (MP03-33) used to treat perennial allergic rhinitis (PAR) to placebo (a nasal spray that contains no medicine). In addition, the study will also compare the safety and effectiveness of an investigational use of another allergy medication (MP03-36) used to treat perennial allergic rhinitis to placebo.

NCT ID: NCT01018693 Completed - Clinical trials for Seasonal Allergic Rhinitis

A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune Tolerance

Start date: November 2009
Phase: Phase 2
Study type: Interventional

The purpose of the study is to determine whether VAK694 when combined with subcutaneous immunotherapy leads to long term immune tolerance to allergen in individuals with seasonal allergic rhinitis.